Prevalence and antimicrobial resistance of uropathogens in different inpatient wards

Acta Microbiologica et Immunologica Hungarica

Volumn 56, Issue 4, 2009, Pages 375-387

  Szasz M ^a   Lehotkai, Nóra ^a   Kristóf, Katalin ^a   Szabó, Dóra ^a   Nagy, K ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Antibiotic resistance; Escherichia coli; Urinary tract infection; Uropathogens

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SCHOOL CHILD; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; WARD;

ESCHERICHIA COLI; NEGIBACTERIA;

EID: 75149150921     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.56.2009.4.7     Document Type: Article

References (31)

1. Joshi, S. G., Litake, G. M., Niphadkar, K. B., Ghole, V. S.: Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J. Infect. Chemother. 9(2), 187-190 (2003).
2. Bean, D. C., Krahe, D., Wareham, D. W.: Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Annals of Clinical Microbiology and Antimicrobials 7, 13 (2008).
3. Tenke, P., Ludwig, E., Kovács, B.: A nem komplikált húgyúti fertõzések diagnosztikája és kezelése a bizonyítékok tükrében. Infektológia és Klinikai Mikrobiológia 3-4, 39-50 (2007).
4. Conway, P. H., Cnaan, A., Zaoutis, T., Henry, B. V., Grundmeier, R. W., Keren, R.: Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. Jama 298(2), 179-186 (2007).
5. Prelog, M., Schiefecker, D., Fille, M., Wurzner, R., Brunner, A., Zimmerhackl, L. B.: Febrile urinary tract infection in children: ampicillin and trimethoprim insufficient as empirical mono-therapy. Pediatric Nephrology (Berlin, Germany) 23(4), 597-602 (2008).
6. Zorc, J. J., Kiddoo, D. A., Shaw, K. N.: Diagnosis and management of pediatric urinary tract infections. Clinical Microbiology Reviews 18(2), 417-422 (2005).
7. Bronsema, D. A., Adams, J. R., Pallares, R., Wenzel, R. P.: Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. J. Urol. 150, 414-416 (1993).
8. Malani, A. N., Kauffman, C. A.: Candida urinary tract infections: treatment options. Expert Rev. Anti Infect. Ther. 5(2), 277-284 (2007).
9. Tolkoff-Rubin, N. E., Conti, D. J., Doran, M., DelVecchio, A., Rubin, R. H.: Fluconazole in the treatment of invasive candidal and cryptococcal infections in organ transplant recipients. Pharmacotherapy 10, 159S-163S (1990).
10. Baerheim, A.: Empirical treatment of uncomplicated cystitis. BMJ (Clinical Researched) 323(7323), 1197-1198 (2001).
11. Bean, D. C., Livermore, D. M., Papa, I., Hall, L. M.: Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. JAC 56, 962-964 (2005).
12. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Mmwr 42(30), 597-599 (1993).
13. Loeb, M., Salama, S., Armstrong-Evans, M., Capretta, G., Olde, J.: A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci. Infect Control Hosp. Epidemiol. 20(11), 760-763 (1999).
14. Corti, G., Giganti, E., Paradisi, F., Nicoletti, P.: Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period. Eur. J. Epidemiol. 9, 335-340 (1993).
15. Esposito, S., Noviello, S., Leone, S.: Catheter-associated urinary tract infections: epidemiology and prevention. Infez. Med. 16(3), 130-143 (2008).
16. Naber, K. G., Bergman, B., Bishop, M. C., Bjerklund-Johansen, T. E., Botto, H., Lobel, B., Jinenez Cruz, F., Selvaggi, F. P.: EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). European Urology 40(5), 576-588 (2001).
17. Reddy, P. P., Evans, M. T., Hughes, P. A., Dangman, B., Cooper, J., Lepow, M. L., Calvano, C. J., Mandell, J.: Antimicrobial prophylaxis in children with vesico-ureteral reflux: a randomized prospective study of continuous therapy vs intermittent therapy vs surveillance. Pediatrics 100, 555-556 (1997).
18. Beier, M. T.: Management of urinary tract infections in the nursing home elderly: a proposed algorithmic approach. International Journal of Antimicrobial Agents 11(3-4), 275-284 (1999).
19. Chou, Y. Y., Lin, T. Y., Lin, J. C., Wang, N. C., Peng, M. Y., Chang, F. Y.: Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. Journal of Microbiology, Immunology, and Infection = Wei mian yu gan ran za zhi 41(2), 124-129 (2008).
20. Wazait, H. D., Patel, H. R., Veer, V., Kelsey, M., Van Der Meulen, J. H., Miller, R. A., Emberton, M.: Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001). BJU International 91(9), 806-809 (2003).
21. Ko, M. C., Liu, C. K., Woung, L. C., Lee, W. K., Jeng, H. S., Lu, S. H., Chiang, H. S., Li, C. Y.: Species and antimicrobial resistance of uropathogens isolated from patients with urinary catheter. The Tohoku Journal of Experimental Medicine 214(4), 311-319 (2008).
22. Manges, A. R., Tabor, H., Tellis, P., Vincent, C., Tellier, P. P.: Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerging Infectious Diseases 14(10), 1575-1583 (2008).
23. Szabó, D.: Importance of extended-spectrum betalactamase production. (Possibility of detection and epidemiology). Infectology and Clinical Microbiology 3, 90-99 (2003).
24. Antibiotic susceptibility of Escherichia coli. NNSR Annual Report 2007, www.oek.hu.
25. Santo, E., Mendonca, M., Martin, S., Martin, J. M.: Multidrug-resistant urinary tract isolates of Escherichia coli from Ribeirao Preto, Sao Paulo, Brazil. BJID 11(6), 575-578 (2007).
26. Lutter, S. A., Currie, M. L., Mitz, L. B., Greenbaum, L. A.: Antibiotic resistance patterns in children hospitalized for urinary tract infections. Archives of Pediatrics & Adolescent Medicine 159(10), 924-928 (2005).
27. Cohen, A. L., Rivara, F. P., Davis, R., Christakis, D. A.: Compliance with guidelines for the medical care of first urinary tract infections in infants: a population-based study. Pediatrics 115(6), 1474-1478 (2005).
28. Bradford, P. A.: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933-951 (2001).
29. Paterson, D. L., Bonomo, R. A.: Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18, 657-686 (2005).
30. Pitout, J. D., Nordmann, P., Laupland, K. B., Poirel, L.: Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56, 52-59 (2005).
31. Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., Carmeli, Y.: Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin. Infect. Dis. 42, 925-934 (2006).